Your browser doesn't support javascript.
loading
A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control.
Parker, William A E; Sagar, Rebecca; Kurdee, Zeyad; Hawkins, Fladia; Naseem, Khalid M; Grant, Peter J; Storey, Robert F; Ajjan, Ramzi A.
Afiliação
  • Parker WAE; Cardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
  • Sagar R; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
  • Kurdee Z; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
  • Hawkins F; Clinical Biochemistry Unit, Pathology Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Naseem KM; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
  • Grant PJ; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
  • Storey RF; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
  • Ajjan RA; Cardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Cardiovasc Diabetol ; 20(1): 238, 2021 12 17.
Article em En | MEDLINE | ID: mdl-34920734

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose / Aspirina / Diabetes Mellitus Tipo 1 / Fibrinolíticos / Controle Glicêmico / Hipoglicemiantes / Insulina Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose / Aspirina / Diabetes Mellitus Tipo 1 / Fibrinolíticos / Controle Glicêmico / Hipoglicemiantes / Insulina Idioma: En Ano de publicação: 2021 Tipo de documento: Article